Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Implement Zero-Based Budgeting Family Expenses with a straightforward approach that assigns every dollar to a category, reducing waste and increasing savings.
18,366 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A senior insider at Septerna sold nearly 12,000 shares in a single move, raising questions for investors. This articl...
Palantir's CEO used a televised interview to question AI pricing models, highlighting data ownership and sovereignty ...
I run my investments on my own, but I still reserve a passive sleeve to reduce risk and simplify life. This is how I ...
A bold take on Tesla's future: could the Optimus robot redefine the company and its stock by 2026? This article lays ...
As MercadoLibre broadens beyond e-commerce, the mercado pago growth engine becomes a pivotal piece of the puzzle. Thi...
Escalating tensions around Iran are triggering market swings and rising energy costs. This report explains how the se...
A new Bitcoin mining cost model, tested with Riot Platforms data, finds power costs can be covered only at a BTC pric...
As Costco’s sales momentum stays strong, investors wonder if the stock can keep delivering. This guide breaks down th...
Kyntra Bio (KYNB) is on investors' radar as 2025 earnings wrap up. This guide breaks down what the Q4 results mean, h...
Long-term success in the stock market isn’t about chasing the next hot tip. It’s about a disciplined plan built on lo...
Coty is navigating a shifting beauty market. This guide breaks down coty (coty) 2026 earnings, what the Q3 transcript...